Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medicine Manufacturing	398.32M	414.95M	475.92M	733.73M	1.05B
Medicine Manufacturing Growth	-4.01%	-12.81%	-35.14%	-30.10%	-4.05%
Unallocated Other Operations	6.40M	1.53M	646.39K	816.20K	1.15M
Unallocated Other Operations Growth	318.14%	136.73%	-20.81%	-28.80%	316.52%
Total	404.72M	416.48M	476.57M	734.55M	1.05B
Total Growth	-2.82%	-12.61%	-35.12%	-30.10%	-3.97%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
East China	116.55M	123.50M	134.62M	185.84M	219.88M
East China Growth	-5.63%	-8.26%	-27.56%	-15.48%	-6.01%
Northeast China	69.20M	72.04M	83.39M	189.73M	235.78M
Northeast China Growth	-3.94%	-13.61%	-56.05%	-19.53%	-0.80%
Central China	61.51M	68.02M	94.57M	156.11M	241.46M
Central China Growth	-9.58%	-28.07%	-39.42%	-35.35%	14.96%
Northern China	57.62M	61.69M	72.48M	87.81M	167.86M
Northern China Growth	-6.60%	-14.88%	-17.46%	-47.69%	12.88%
Southwest China	55.19M	50.06M	48.50M	53.64M	80.30M
Southwest China Growth	10.25%	3.22%	-9.58%	-33.20%	-32.62%
South China	36.34M	27.75M	27.91M	43.95M	75.67M
South China Growth	30.95%	-0.58%	-36.49%	-41.93%	-34.78%
Northwestern China	8.30M	13.42M	15.10M	17.47M	29.86M
Northwestern China Growth	-38.12%	-11.16%	-13.56%	-41.48%	4.12%
Total	404.72M	416.48M	476.57M	734.55M	1.05B
Total Growth	-2.82%	-12.61%	-35.12%	-30.10%	-3.97%

Source: S&P Global Market Intelligence.